Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome

Thorax

Volumn 51, Issue 9, 1996, Pages 907-913

  Wang, Jiu Yao ^a,b   Yeh, Tsu Fuh ^b   Lin, Yu Chih ^b   Miyamura, Kazuo ^a   Holmskov, Uffe ^a   Reid, Kenneth B M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bronchopulmonary dysplasia; Dexamethasone; Respiratory distress syndrome (RDS); Surfactant proteins A and D (SP A and SP D); Tracheal aspirates

Indexed keywords

DEXAMETHASONE; LUNG SURFACTANT; PLACEBO; SURFACTANT ASSOCIATED PROTEIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LUNG ASPIRATION; LUNG FUNCTION; MALE; NEWBORN; POSTNATAL CARE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

EID: 0029739010     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.9.907     Document Type: Article

References (34)

1. Farrell PM, Avery MA. Hyaline membrane disease. Am Rev Respir Dis 1975;111:657-88.
2. Johansson J, Curstedt T, Robertson B. The proteins of the surfactant system. Eur Respir J 1994;7:372-91.
3. Yu SH, Possmayer F. Role of pulmonary surfactant associated proteins in the surface-active property of phospholipid mixtures. Biochim Biophys Acta 1990;1046:233-41.
4. Weaver TE, Whitsett JA. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem J 1991;173:249-64.
5. Suzuki Y, Fujita Y, Kogishi K. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am Rev Respir Dis 1989; 140:75-81.
6. Rice WR, Ross GF, Singleton FM, Dingle S, Whitsett JA. Surfactant-associated protein inhibits phospholipid secretion from type II cells. J Appl Physiol 1987;63:692-8.
7. Persson A, Chang D, Rust K, Moxley M, Longmore W, Crouch E. Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. Biochemistry 1989;28:63611-67.
8. Lu JH, Willis AC, Reid KBM. Purification, characterization and cDNA cloning of human lung surfactant protein D. Biochem J 1992;284:795-802.
9. Lim BL, Wang JY, Holmskov U, Hoppe HJ, Reid KBM. Expression of the carbohydrate recognition domain of lung surfactant protein D and demonstration of the binding to lipopolysaccharides of Gram-negative bacteria. Biochem Biophys Res Commun 1994;202:1674-80.
10. Wright JR, Youmans DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol 1993;264:L338-44.
11. Holmskov U, Malhotra R, Sim RB, Jensenius JC. Collectins: collagenous C-type lectins of the innate immune dense system. Immunol Today 1994;15:67-74.
12. Van Iwaarden JF. Surfactant and pulmonary defense system. In: Robertson B, Van Golde, LMG, Batenburg JJ, eds. Pulmonary surfactant: from molecular biology to clinical practice. Amsterdam: Elsevier Science, 1992:215-29.
13. Hong SCL, Levine I. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci USA 1976;73:1730-4.
14. Mammal MC, Johnson DE, Green TP, Thompson TR. Controlled trial of dexamethasone in respiratory dependent infants with bronchopulmonary dysplasia. Lancet 1983;i:1356-8.
15. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr 1990;117:273-82.
16. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res 1994;36:122-8.
17. Iannuzzi DM, Ertsey R, Ballard PL. Biphasic glucocorticoid regulation of pulmonary SP-A: characterization of inhibitory process. Am J Physiol 1993;264:L236-44.
18. Deterding RR, Shimizu H, Fisher JH, Shannon JM. Regulation of surfactant protein D expression by glucocorticoids in vitro and in vivo. Am J Respir Cell Mol Biol 1994;10:30-7.
19. Fraslon C, Batenburg JJ. Pre-translational regulation of lipid synthesizing enzymes and surfactant protein in fetal rat lung in explant culture. FEBS Lett 1993;325:285-90.
20. Miyamura K, Malhotra R, Hoppe HJ, Reid KBM, Phizackerley PJR, Macpherson P, et al. Surfactant protein A (SP-A) and D (SP-D): levels in human amniotic fluid and localization in the fetal membranes. Biochim Biophys Acta 1994;1210:303-7.
21. Chida S, Phelps D, Cordle C, Soll R, Floros J, Taeusch HW. Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy. Am Rev Respir Dis 1988;137:943-7.
22. Groneck P, Reuss D, Gotze-Speer B, Speer CP. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 1993;122:938-44.
23. Fussell JC, Kelly FJ. Effects of dexamethasone on lung protein turnover. Biochem J 1991;273:93-7.
24. DeMello DE, Phelps DS, Patel G, Floros J, Lagunoff D. Expression of the 35 kDa and low molecular weight surfactant-associated proteins in the lungs of infants dying with respiratory syndrome. Am J Pathol 1988;134:1285-93.
25. Gerdes JS, Abbasi S, Karp K, Hull W, Whitsett JA. Surfactant protein-A in bronchoalveolar lavage fluid from neonates with RDS on conventional and high-frequency oscillatory ventilation. Pediatr Pulmonol 1990;9:166-9.
26. Stevens PA, Schadow B, Bartholain S, Segerer H, Obladen M. Surfactant protein A in the course of respiratory distress syndrome. Eur J Paediatr 1992;151:596-600.
27. Moya FR, Montes HF, Thomas VL, Mouzinho AM, Smith JF, Rosenfeld CR. Surfactant protein A and saturated phosphatidylcholine in respiratory distress syndrome. Am J Respir Crit Care Med 1994;150:1672-7.
28. Ashton MR, Postle AD, Smith DE, Hall MA. Surfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease. Arch Dis Child 1994;71:F114-7.
29. Voder MC, Chua R, Tepper R. Effects of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis 1991;143:1044-8.
30. Ogasawara Y, Kuroki Y, Tsuzuki A, Ueda S, Misaki H, Akino T. Pre- and postnatal stimulation of pulmonary surfactant protein D by in vivo dexamethasone treatment of rats. Life Sci 1992;50:1761-7.
31. Floros J, Phelps DS, Harding HP, Church S, Ware J. Postnatal stimulation of rat surfactant protein A synthesis by dexamethasone. Am J Physiol 1989;257:L137-43.
32. Gerdes JS, Harris MC, Polin RA. Effect of dexamethasone and indomethacin on elastase, α1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonate. J Pediatr 1988;113:727-31.
33. Van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, Van Golde LMG. Pulmonary surfactant protein A enhances the host defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990;2:91-8.
34. Wright JR, Yumans DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol 1993;264:L338-44.